Journal of cancer research and clinical oncology
-
J. Cancer Res. Clin. Oncol. · Jun 2010
Comparative StudyA new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma.
Prediction of the life expectancy of a patient with unresectable hepatocellular carcinoma (HCC) remains difficult. The aims of the study were to construct a new staging scheme for patients with unresectable HCC and to compare the discriminatory ability of the staging scheme with the Okuda and CLIP score and TNM staging system in a cohort of patients with unresectable HCC. ⋯ The new staging system, accounting for both liver function and tumor characteristics, can accurately identify patients with different prognoses, particularly in the advanced phases of HCC. It should be useful as the only tool that can be applied for patients with unresectable HCC.